Yeah why would they only delay a week if it were not one of the first two.I've said all along Pfizer wanted Intellect its pipeline platforms and patents.
They don't want just a license/contract they want everything.
250 to 500 million would be a steal.Pfizer with its unlimited funds could take this platform CONJUMAB and make a killing.I'm talking about 10's of billions.
In 2013 we plan to move forward aggressively with our CONJUMAB and tau immunotherapy programs. These activities are expected to generate data that will increase the enterprise value of each program and attract new partnership opportunities that could result in substantial license revenues. This strategy is based on recent discussions with global pharmaceutical companies, several of which have expressed high levels of interest in these preclinical programs.
Market Data 
Markets 
AI
